Related Experiment Videos

Hypertrophic cardiomyopathy evolving into a hypokinetic and dilated left ventricle: coronary embolization as a

M B Gravanis1, P H Robinson, G L Hertzler

  • 1Department of Pathology, Emory University School of Medicine, Atlanta, GA 30322.

Clinical Cardiology
|July 1, 1990
PubMed

Insights

Hypertrophic cardiomyopathy can progress to a dilated heart over time. This case study shows myocardial scars and thrombi in a heart transplant patient, offering insights into disease progression.

Area of Science:

  • Cardiology
  • Pathology
  • Cardiovascular Research

Background:

  • Hypertrophic cardiomyopathy (HCM) is a primary cardiac disease characterized by left ventricular hypertrophy.
  • The natural history of HCM can involve progression to dilated cardiomyopathy (DCM) in some cases.
  • Understanding the transition from HCM to DCM is crucial for patient management and therapeutic development.

Observation:

  • A nine-year follow-up of an HCM patient revealed a transition to a hypokinetic and dilated left ventricle.
  • Morphologic studies of the explanted native heart post-transplantation were performed.
  • The native heart displayed hallmarks of both HCM and left ventricular dilatation.

Findings:

  • Histopathological examination confirmed the presence of hypertrophic cardiomyopathy stigmata.
  • Evidence of left ventricular dilatation was observed.
  • Multiple myocardial scars in both ventricles suggested prior ischemic events, likely from coronary embolization secondary to left ventricular mural thrombi.

Implications:

  • This case highlights a potential, albeit rare, progression pathway for hypertrophic cardiomyopathy.
  • Coronary embolization from mural thrombi is proposed as a significant pathogenetic mechanism.
  • Further research into the mechanisms driving HCM to DCM transition is warranted.

Related Concept Videos